Select Bibliography

Filter by any of these (after searching):

Wolf, S. L.

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 5 items

Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1

Loprinzi, C. L. , Reeves, B. N. , Dakhil, S. R. , Sloan, J. A. ... - - J. Clin. Oncol. - 2011

Manuscript - Primary - Primary - Health Outcome - N08C1

Natural history of paclitaxel-associated acute pain syndrome (P-APS): NCCTG trial N08C1

Reeves, B. , Dakhil, S. R. , Sloan, J. A. , Kamal, A. , Wolf, S. L. ... - ASCO - J. Clin. Oncol. - 2010

Abstract - Primary - Primary - Health Outcome - N08C1

The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA

Wolf, S. L. , Barton, D. L. , Qin, R. , Wos, E. J. , Sloan, J. A. ... - - Support Care Cancer - 2012

Manuscript - Secondary - Primary - Health Outcome - N06CA

Relationship of sensory symptoms and motor function in patients with chemotherapy-induced peripheral neuropathy (CIPN) utilizing the EORTC QLQ CIPN20: NCCTG study N06CA

Wolf, S. L. , Qin, R. , Barton, D. L. , Sloan, J. A. , Liu, H. ... - ASCO - J. Clin. Oncol. - 2009

Abstract - Secondary - Primary - Health Outcome - N06CA

Evaluation of a urea/lactic acid-based topical keratolytic agent (ULABTKA) for prevention of capecitabine-induced hand and foot syndrome (HFS): NCCTG trial N05C5

Wolf, S. L. , Qin, R. , Menon, S. P. , Rowland, K. M., Jr ... - ASCO - J. Clin. Oncol. - 2010

Abstract - Primary - Primary - Symptom Inter - N05C5